Patient-reported impact of symptoms in schizophrenia scale (PRISS)
In order to understand how people with schizophrenia feel and are affected by the clinical symptomatology of the disease, and how they perceive the care and treatment they receive, the group has collaborated in the development of a PRO (Patiente Reported Outcomes) scale to measure the self-reported experiences of people with schizophrenia.
Knowing people’s perceptions of their own treatment can not only improve the clinical effectiveness of interventions, but can also be useful in improving the quality of health care.
The PRISS scale is a questionnaire that allows the assessment of the perspective of the person affected by schizophrenia, while providing valuable complementary information to the clinical assessment.
This instrument presents a series of items divided into three blocks: productive subjective experiences, affective-negative subjective experiences and excitation.
Have a look at the PRISS scale.
In addition to the development of this measurement scale, the group is also involved in the OPADE project, among others, which aims to analyse the genetic and metabolic profile of people with major depression in order to personalise their pharmacological treatment, reduce the side effects of the medication, increase adherence and improve the effectiveness of the entire treatment. To do this, the project combines multi-omics data analysis with a predictive tool based on artificial intelligence (AI). They also investigate the correlation between the metabolic thread and non-pharmacological treatments.
More information about the OPADE project.
PI: Jordi Cid Colom
COPI: Eva Frigola Capell
Research group: Mental Health and Addictions Girona
Institution: Institut d’Investigació Biomèdica de Girona Dr. Josep Trueta (IDIBGI)
Visit the group website here.
For further information contact us.